Vascular complications of sickle cell disease
- 28 March 2018
- journal article
- research article
- Published by IOS Press in Clinical Hemorheology and Microcirculation
- Vol. 68 (2-3), 205-221
- https://doi.org/10.3233/ch-189008
Abstract
Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis. Multiple lines of evKeywords
This publication has 145 references indexed in Scilit:
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionPediatric Blood & Cancer, 2010
- Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell DiseaseTransplantation and Cellular Therapy, 2010
- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell DiseaseThe New England Journal of Medicine, 2009
- Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular RiskJournal of Invasive Cardiology, 2009
- Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyureaAmerican Journal of Hematology, 2009
- Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathBritish Journal of Haematology, 2009
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseaseJournal of Invasive Cardiology, 2007